1Dienstag J L. Hepatitis B virus infection. N Engl J Med, 2008, 359: 1486-1500.
2Tsiang M, Gibbs Cs. Analysis of HBV virus dynamics and its impact on antiviral development. Methods Mol Med, 2004, 96= 361-377.
3Raimondo G, Pollicino T, Cacciola I, et al. Occult hepatitis Bvirus infection. J Hepatol, 2007, 46: 160-170.
4Marusawa H, Imoto S, Ueda Y, et al. Reactivation of latently infected hepatitis B virus in a leukemia patient with antibodies to hepatitis B core antigen. J Gastroenterol, 2001, 36: 633-636.
5Hui Ck, Cheung Ww, Zhang Hy. Kinetics and risk of denovo hepatitis B infection in HBsAg negative patients undergoingcytotoxic chemotherapy. Gastroenterology, 2006: 59-68.
1Chinese Society of Hepatology and Chinese Society of Infectious Diseases,Chinese Medical Association. 42 Dongsi Xidajie,Beijing 100710,China.慢性乙型肝炎防治指南[J].中华肝脏病杂志,2005,13(12):881-891. 被引量：1931
6Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association.肝衰竭诊疗指南[J].中华肝脏病杂志,2006,14(9):643-646. 被引量：829
